NIPT prenatal testing: St George's plans an externally provided service
St George's University Hospitals NHS Foundation Trust plans to buy an externally provided non-invasive prenatal testing (NIPT) service. NIPT is a blood test taken from the mother during pregnancy. It uses DNA analysis to show whether the baby has a high chance of a chromosomal condition.
The supplier would host and run the service, including its software, Laboratory Information Management System, equipment and reagents, and keep the equipment maintained. The service handles about 5,000 patients a year at St George's. The South West London Procurement Partnership is running the market engagement for the trust.
The contract is estimated at £2m. It would run for two years, with two optional one-year extensions, and the service is due to start in November 2027.
- What
- PCR and molecular diagnostic platforms
- Estimated value
- £2m
- How it will be bought
- Not published
- Responses due
- Not published
- Contract dates
- Not published